To apply for an EIND the disease must be considere
Post# of 148172
(Total Views: 718)
Posted On: 10/19/2020 2:45:38 PM
To apply for an EIND the disease must be considered serious or life threatening I don't know if the FDA would consider Lyme disease either. One can only try. The first step would be to contact Cytodyn. The second would be for the doctor to get written consent from the patient and approval from the Institutional Review Board at their hospital. Next step contact the FDA.
The other option would be off-label use when leronlimab is approved for any indication.
The other option would be off-label use when leronlimab is approved for any indication.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼